MARIA DE LA CRUZ: Open Payments
NPI 1417428095 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 33 payments from 9 companies in 2025. Trend: 2023 $111 · 2024 $333 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $559 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Biogen, Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
Products named: VRAYLAR, INVEGA SUSTENNA, LEQEMBI, COBENFY, Auvelity, SPRAVATO, ERZOFRI EXTENDED-RELEASE, LYBALVI.
Industry payments across FL — which companies pay providers there.
